Re: The License, Research and Development Agreement dated August 2, 2000 between MethylGene, Inc. (MG) and MGI PHARMA, INC. (MGI) (the “Agreement”)License, Research and Development Agreement • February 24th, 2004 • Mgi Pharma Inc • Pharmaceutical preparations
The purpose of this letter is to amend and capture the current understanding between our companies regarding the status of the above referenced Agreement. With this letter, MethylGene agrees that:
